In addition to the previous functional study of risk variants, we investigated epigenetic regulation of TOX3 expression on breast tumors in silico, revealing an inverse correlation between subtype-specific expression of TOX3 and CpG site methylation of the promoter. This evidence concerns the gene TOX3 and breast neoplasm.